Area of research
Obstetrics and Gynecology · Reproductive Medicine
Research interest
Research interests include Endometrial and Cervical Cancer Treatments, Ovarian cancer diagnosis and treatment, Cervical Cancer and HPV Research, and Reproductive tract infections research.
Dose finding, bioavailability, and PK-PD of oral triapine with concurrent chemoradiation for locally advanced cervical cancer and vaginal cancer (ETCTN 9892)
Niraparib and dostarlimab for the treatment of recurrent platinum-resistant ovarian cancer: results of a Phase II study (MOONSTONE/GOG-3032)
Ofranergene Obadenovec (Ofra-Vec, VB-111) With Weekly Paclitaxel for Platinum-Resistant Ovarian Cancer: Randomized Controlled Phase III Trial (OVAL Study/GOG 3018)
The Genomic Landscape of Vulvar Squamous Cell Carcinoma
A qualitative analysis of female patient perspectives on physician communication regarding sexual dysfunction associated with pelvic radiotherapy
Primary ovarian lymphoma: A case report
The Vaginal Microbiome is Associated with Endometrial Cancer Grade and Histology
Retreatment of chemotherapy-resistant metastatic choriocarcinoma with immunotherapy
Rationale for combination of paclitaxel and CDK4/6 inhibitor in ovarian cancer therapy — non-mitotic mechanisms of paclitaxel
Leveraging teachable moments in cancer prevention by improving HPV vaccination in health professional students (HPS): A systematic review
Uterine Sarcomas: How to Navigate an Ever-Growing List of Subtypes
MOONSTONE/GOG-3032: Interim analysis of a phase 2 study of niraparib + dostarlimab in patients (pts) with platinum-resistant ovarian cancer (PROC).
Endometrial cancer from early to advanced-stage disease: an update for radiologists
Low-grade serous ovarian cancer: State of the science
Identifying disparities in germline and somatic testing for ovarian cancer
Impact of molecular testing in clinical practice in gynecologic cancers
Polypharmacy in Patients with Ovarian Cancer
Uterine rhabdomyosarcoma in adults
Gynecologic cancer survivor preferences for long-term surveillance
A randomized phase II study of letrozole vs. observation in patients with newly diagnosed uterine leiomyosarcoma (uLMS)
Wilms Tumor of the Uterus
Complete Serologic Response to Pembrolizumab in a Woman With Chemoresistant Metastatic Choriocarcinoma
Variation in type II endometrial cancer risk by Hispanic subpopulation: An exploratory analysis
SMARCA4 germline gene mutation in a patient with epithelial ovarian: A case report
The obese endometrial cancer patient: how do we effectively improve morbidity and mortality in this patient population?